Authors
Loading...
Cohort study reveals predictors of top-quartile healthcare costs in pediatric inflammatory bowel disease, highlighting opportunities for early financial and clinical risk mitigation.
Kuenzig et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: